Chemoinformaics analysis of Kaur-16-en-19-oic acid
Molecular Weight | 302.458 | nRot | 1 |
Heavy Atom Molecular Weight | 272.218 | nRig | 21 |
Exact Molecular Weight | 302.225 | nRing | 4 |
Solubility: LogS | -3.521 | nHRing | 0 |
Solubility: LogP | 4.802 | No. of Aliphatic Rings | 4 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 55.0078 |
nHD | 1 | BPOL | 30.9642 |
QED | 0.689 |
Synth | 5.468 |
Natural Product Likeliness | 3.104 |
NR-PPAR-gamma | 0.082 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.022 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -5.691 |
MDCK | 0.00000626 |
BBB | 0.297 |
PPB | 0.824222 |
VDSS | 0.383 |
FU | 0.119383 |
CYP1A2-inh | 0.014 |
CYP1A2-sub | 0.566 |
CYP2c19-inh | 0.016 |
CYP2c19-sub | 0.777 |
CYP2c9-inh | 0.077 |
CYP2c9-sub | 0.146 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.224 |
CYP3a4-inh | 0.682 |
CYP3a4-sub | 0.158 |
CL | 2.795 |
T12 | 0.145 |
hERG | 0.015 |
Ames | 0.007 |
ROA | 0.42 |
SkinSen | 0.093 |
Carcinogencity | 0.846 |
EI | 0.049 |
Respiratory | 0.965 |
NR-Aromatase | 0.459 |
Antiviral | No |
Prediction | 0.692111 |